TERN Similar Chart Price Prediction
The price of TERN is predicted to go up 0.32%, based on the high correlation periods with HP. The similarity of these two price pattern on the periods is 94.21%.
TERN
HP
Up: 0.32%Similarity: 94.21%
TERN Revenue Forecast
TERN EPS Forecast
TERN FAQs
What is bull’s view on TERN?
What is bear's view on TERN?
What is TERN eps forecast for next quarter？
TERN Analyst's Forecast
Jay Olson
Oppenheimer
Buy
2024-12-04
Price Target
$17 → $20
Upside
+182.49%
Oppenheimer raised the firm's price target on Terns Pharmaceuticals to $20 from $17 and keeps an Outperform rating on the shares. Terns reported an interim update on TERN-701's Phase 1 study in chronic myeloid leukemia, providing "encouraging" three month efficacy and safety data that reinforce confidence surrounding its differentiated profile over existing tyrosine kinase inhibitors, the analyst tells investors in a research note. The firm believes TERN-701's emerging profile supports development in earlier-line settings, and its three-month performance strengthens its optimism surrounding longer-term major molecular response data, expected in Q4 of 2025.
Jay Olson
Oppenheimer
Buy
2024-10-31
Price Target
$17
Upside
+147.81%
